We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Early Serum Creatinine Predicts Post-Surgery AKI

By LabMedica International staff writers
Posted on 05 Apr 2017
Acute Kidney Injury (AKI) is a common and serious complication of cardiac surgery. More...
Mild AKI occurs in nearly one in five patients undergoing cardiac surgery and is associated with a 19-fold increase in short-term mortality.

It is important to identify patients who are at risk of developing AKI post cardiac surgery as historically and again recently, it has been shown that early nephrology referral for patients who develop AKI results in improved outcomes.

Scientists at the Monash Medical Centre and their colleagues prospectively studied 196 consecutive patients undergoing elective (on-pump) cardiac surgery. All patients undergoing on pump cardiac surgery had urinalysis for proteinuria and serum urea and creatinine determined within one month prior to surgery. The study population was predominantly male (73.5%) with the median age of enrolled participants being 70.8 years (range 30–91).

Serum urea and creatinine were subsequently collected immediately upon arrival to intensive care unit (ICU), within two hours of surgery completion, daily for 48 hours, and prior to discharge. Urinalysis was performed using Roche Combur 10 Test Strips and proteinuria was graded according to severity ranging from no detectable protein at 0 to a maximum score of 3 as annotated on the urinalysis kit. Subjects were classified as having proteinuria if the test strip score was 1 or higher.

The scientists reported that the mean pre-operative creatinine was 86 μmmol/L (range 40–246; SD 27.0) with a mean eGFR of 75.63 mL/min/1.73 m2 (range 21.59–118.8 ± 18.75) and 19% of the cohort had diabetes and 40 (20.4%) patients developed AKI postoperatively. Hypertension (OR 2.64), diabetes (OR 2.25), proteinuria (OR 2.48), and a lower baseline eGFR (OR 0.74) were associated with AKI in univariate analysis. A fall of greater than 15% from baseline in the early post-operative serum creatinine was protective for the development of AKI (OR = 0.34). On its own, the change in early post-operative serum creatinine was poorly predictive for AKI.

The authors concluded that a rise of greater than 15% in serum creatinine (sCr) over baseline, taken within two hours of arrival to ICU, equated to an odds ratio of seven for the development of AKI. This is important as sCr is an inexpensive, readily available test and measurements of early sCr could easily be incorporated into clinical practice, even in resource poor settings. They suggest that patients who demonstrate an increase in early sCr should be referred to a nephrologist in a timely manner. This would enable early interventions and potentially improve outcomes. The study was published on March 16, 2017, in the journal BMC Nephrology.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.